Fostering innovative product development for neglected tropical diseases through partnerships.
Neglected tropical diseases are a group of infectious diseases that threaten and impact a significant portion of individuals living in low- and middle-income countries. Healthcare product R&D, which has been relatively limited for this group of infectious diseases, is timely and requires significant risk and resource investment by companies. Regardless of these costs, the global community has recognized the impact on human health that developing products for these diseases could have. Incentives, including 'push' and 'pull' funding, and platforms that support sharing of intellectual property through partnerships, such as The World Intellectual Property Organization Re:Search, are driving R&D. These mechanisms entice more organizations to participate in global health product development activities, and combine assets and capabilities while reducing costs and risk.
BIO Ventures for Global Health Seattle, WA, USA.
Amy
A
Starr
BIO Ventures for Global Health Seattle, WA, USA.
Katy M
KM
Graef
BIO Ventures for Global Health Seattle, WA, USA.
Jennifer
J
Dent
D003141:Communicable Diseases / Q000188:drug therapy*; D003906:Developing Countries; D055808:Drug Discovery / Q000379:methods*; D004345:Drug Industry / Q000379:methods*; D006801:Humans; D018973:Intellectual Property; D007391:International Cooperation; D058069:Neglected Diseases / Q000188:drug therapy*
BIO Ventures for Global Health; WIPO Re:Search; neglected tropical diseases